Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.
Ratings for Vertex Pharmaceuticals (NASDAQ: VRTX) were provided by 15 analysts in the past three months, showcasing a mix of ...
The FDA granted breakthrough therapy designation to a Vertex Pharmaceuticals kidney disease drug.
Zacks Investment Research on MSN
Vertex (VRTX) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...
Vertex also announced enrollment completion of the IA cohort of AMPLITUDE, a global Phase 2/3 clinical trial designed to assess the impact of ...
Live Science on MSN
Scientists asked ChatGPT to solve a math problem from more than 2,000 years ago — how it answered it surprised them
We've wondered for centuries whether knowledge is latent and innate or learned and grasped through experience, and a new ...
Hezbollah leader Hassan Nasrallah was killed in an Israeli airstrike on Friday. Israel is firing strikes into Lebanon as the conflict in the Middle East intensifies. Israel believes it has eliminated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback